Ewa Malecka-Wojciesko
Overview
Explore the profile of Ewa Malecka-Wojciesko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mokrowiecka A, Kopczynska M, Borkowska A, Malecka-Wojciesko E
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941688
Affective temperaments can be considered the subclinical manifestations of affective and stress-related disorders, which could have a relationship with many chronic diseases. The purpose of this study was to explore...
2.
Kowalski M, Domzal-Magrowska D, Malecka-Wojciesko E
Foods
. 2025 Jan;
14(2.
PMID: 39856963
Background: Celiac disease (CD) is a chronic, permanent, gluten-dependent disease that manifests itself with inflammation of the small intestine and malabsorption in genetically predisposed individuals with HLA-DQ2 and -DQ8 (human...
3.
Frak W, Domzal-Magrowska D, Malecka-Wojciesko E
Prz Gastroenterol
. 2025 Jan;
16(4):454-455.
PMID: 39810870
No abstract available.
4.
Kowalski M, Domzal-Magrowska D, Szczesniak P, Bulska M, Orszulak-Michalak D, Malecka-Wojciesko E
Foods
. 2025 Jan;
14(1.
PMID: 39796366
Background: Celiac disease (CD) is an autoimmune disease that results from the interaction of genetic, immune, and environmental factors. According to the 2020 European Society for Pediatric Gastroenterology Hepatology and...
5.
Fabisiak A, Caban M, Dudek P, Strigac A, Malecka-Wojciesko E, Talar-Wojnarowska R
Therap Adv Gastroenterol
. 2025 Jan;
18:17562848241309871.
PMID: 39758970
Inflammatory bowel diseases (IBDs), primarily encompassing ulcerative colitis and Crohn's disease, represent a challenging spectrum of disorders with a multifaceted pathogenesis. Despite the array of available treatments, a demand for...
6.
Wlodarczyk B, Durko L, Walczak K, Talar-Wojnarowska R, Malecka-Wojciesko E
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596226
Disturbances in carbohydrate metabolism are suggested to be the early symptoms of pancreatic ductal adenocarcinoma (PDAC). The accumulated data suggests that endocrine function-related biomarkers may represent a breakthrough in the...
7.
Rutkowski K, Udrycka K, Wlodarczyk B, Malecka-Wojciesko E
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407743
The aim of this paper is to raise awareness of MC as a clinically significant condition and to highlight its under-recognition, risk factors, diagnosis, management, and complications. This paper underlines...
8.
Talar-Wojnarowska R, Fabisiak A, Zatorski H, Ploszka K, Blaziak K, Fendler W, et al.
Front Med (Lausanne)
. 2024 Oct;
11:1458998.
PMID: 39364021
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a complex etiology that affects the large intestine. Characterized by chronic, bloody diarrhea, UC can lead to severe complications,...
9.
Strigac A, Caban M, Malecka-Wojciesko E, Talar-Wojnarowska R
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200823
The management of inflammatory bowel diseases (IBD) requires weighing an individual patient's therapeutic benefits and therapy-related complication risks. The immunomodulators that have been commonly used so far in IBD therapy...
10.
Rogowska J, Semeradt J, Durko L, Malecka-Wojciesko E
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200786
Pancreatic cystic lesions (PCLs) are increasingly diagnosed owing to the wide use of cross-sectional imaging techniques. Accurate identification of PCL categories is critical for determining the indications for surgical intervention...